Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc (SPRO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.5775 -0.0124 (-2.10%) 04/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.5839 +0.0064 (+1.11%) 17:40 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.5220
Day High
0.6000
Open 0.6000
Previous Close 0.5899 0.5899
Volume 123,900 123,900
Avg Vol 175,995 175,995
Stochastic %K 16.68% 16.68%
Weighted Alpha -67.21 -67.21
5-Day Change -0.0465 (-7.45%) -0.0465 (-7.45%)
52-Week Range 0.5052 - 1.7500 0.5052 - 1.7500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,976
  • Shares Outstanding, K 55,901
  • Annual Sales, $ 47,980 K
  • Annual Income, $ -68,570 K
  • EBIT $ -72 M
  • EBITDA $ -72 M
  • 60-Month Beta 0.64
  • Price/Sales 0.65
  • Price/Cash Flow N/A
  • Price/Book 0.66
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.27
  • Most Recent Earnings $-0.38 on 03/27/25
  • Next Earnings Date 05/21/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 622.58% ( +245.07%)
  • Historical Volatility 73.01%
  • IV Percentile 93%
  • IV Rank 54.80%
  • IV High 1,109.16% on 04/03/25
  • IV Low 32.70% on 07/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,309
  • Open Int (30-Day) 1,321

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.44
  • Number of Estimates 2
  • High Estimate -0.33
  • Low Estimate -0.55
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -83.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5052 +14.31%
on 04/09/25
Period Open: 0.7520
0.9200 -37.23%
on 03/25/25
-0.1745 (-23.20%)
since 03/10/25
3-Month
0.5052 +14.31%
on 04/09/25
Period Open: 0.9800
1.0100 -42.82%
on 01/13/25
-0.4025 (-41.07%)
since 01/10/25
52-Week
0.5052 +14.31%
on 04/09/25
Period Open: 1.7000
1.7500 -67.00%
on 04/11/24
-1.1225 (-66.03%)
since 04/10/24

Most Recent Stories

More News
Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update

SPRO : 0.5775 (-2.10%)
Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025

SPRO : 0.5775 (-2.10%)
UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

SPRO : 0.5775 (-2.10%)
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

SPRO : 0.5775 (-2.10%)
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

SPRO : 0.5775 (-2.10%)
Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

Shares of small biotech Arcutis Biotherapeutics ARQT have surged nearly three times in market value in the past year.The upside has been primarily driven by the positive regulatory updates regarding the...

CTMX : 0.4946 (-1.14%)
CSTL : 19.30 (-4.03%)
ARQT : 13.44 (-7.76%)
SPRO : 0.5775 (-2.10%)
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug

Shares of Mesoblast Limited MESO have soared 80% in one month following the FDA approval of remestemcel-L as the only approved therapy for steroid-refractory acute graft versus host disease (SR-aGVHD)...

MESO : 10.40 (-6.14%)
CTMX : 0.4946 (-1.14%)
CSTL : 19.30 (-4.03%)
SPRO : 0.5775 (-2.10%)
CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Shares of Capricor Therapeutics CAPR gained 8.4% on Thursday following the completion of the submission of a biologics license application (BLA) to the FDA seeking full approval for deramiocel to treat...

CTMX : 0.4946 (-1.14%)
CSTL : 19.30 (-4.03%)
SPRO : 0.5775 (-2.10%)
CAPR : 8.88 (-5.53%)
Neumora Stock Hits Record Low on Depression Drug Study Failure

Shares of Neumora Therapeutics NMRA lost more than 80% on Thursday after reporting the failure of its lead pipeline drug, navacaprant, in a late-stage study for major depressive disorder (MDD).The phase...

CTMX : 0.4946 (-1.14%)
CSTL : 19.30 (-4.03%)
NMRA : 0.7200 (-4.72%)
SPRO : 0.5775 (-2.10%)
VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag

Shares of Verastem Oncology VSTM rallied 40.9% on Tuesday after it announced that the FDA has accepted the new drug application (NDA) for its avutometinib/defactinib combo therapy to treat adult patients...

CTMX : 0.4946 (-1.14%)
CSTL : 19.30 (-4.03%)
SPRO : 0.5775 (-2.10%)
VSTM : 4.52 (-14.39%)

Business Summary

Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.

See More

Key Turning Points

3rd Resistance Point 0.6890
2nd Resistance Point 0.6445
1st Resistance Point 0.6110
Last Price 0.5775
1st Support Level 0.5330
2nd Support Level 0.4885
3rd Support Level 0.4550

See More

52-Week High 1.7500
Fibonacci 61.8% 1.2745
Fibonacci 50% 1.1276
Fibonacci 38.2% 0.9807
Last Price 0.5775
52-Week Low 0.5052

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar